Detalles de la búsqueda
1.
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Br J Haematol
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710589
2.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol
; 98(9): E237-E240, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382471
3.
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Cancers (Basel)
; 16(6)2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539430
4.
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Front Immunol
; 15: 1393485, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38807597
5.
Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature.
Curr Oncol
; 30(9): 8255-8265, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37754514
6.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Front Oncol
; 13: 1212752, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427126
7.
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Cancers (Basel)
; 14(6)2022 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326711
8.
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Curr Oncol
; 30(1): 274-283, 2022 12 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661671
9.
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study.
Cancers (Basel)
; 14(1)2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008372
10.
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL.
Front Oncol
; 9: 198, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31001470
Resultados
1 -
10
de 10
1
Próxima >
>>